ERBB2 and cancer: In addition, in pre-malignant lesions, CCL2 produced by cancer cells and myeloid cells attracts CD206+/Tie2+ macrophages and induces Wnt-1 upregulation that, in response, downregulates E-cadherin junctions in the HER2+ early cancer cells.